Health

Extreme Open Source Science

"Science is about being bold and taking risks."

"Science is about being bold and taking risks."

“Science is about being bold and taking risks,” saidTim Willson, Ph.D., who runs the Structural Genomics Consortium (SGC) hub at Carolina.

For the SGC being bold means launching the Extreme Open Science Initiative, which encourages SGC scientists in labs around the world to publish their notes online.

“Much of the research we have in the SGC lab is about picking bold, novel approaches to solving scientific problems. To innovate on innovation, as it were.  And one of these innovations is our open lab notebook experiment.”

“At the end of the day, you want to collaborate with the best scientists in the world. If you can get this information out there, it makes that easier,” Willson said.

Read the complete Carolina Story from the UNC Eshelman School of Pharmacy…Opens in new window

This is story number 88 in the Carolina Stories 225th Anniversary Edition magazine.

UNC Eshelman School of Pharmacy Funding Priorities

    Readers Also Viewed...

    A group shot of Owen Fenton and his team in the Fenton Lab
    Faculty Support

    Attracting Expertise

    Owen Fenton sees coming to Carolina as a win for his research interests.

    Tim Willson stands with arms crossed with lab equipment in the background.
    Faculty Support

    Bringing the dark proteome into the light

    A Q&A with Tim Willson, the inaugural Harold Kohn Distinguished Professor in Open Science Drug Discovery

    A UNC Eshelman School of Pharmacy student takes notes during class.
    Health

    Strengthening Diversity, Improving Care

    Grants to the UNC Eshelman School of Pharmacy will support diversity and rural care programs.

    Nate Hathaway in the CRISPR Screening Facility
    Research

    UNC-Chapel Hill Awarded Funding for Study of Malan Syndrome

    UNC Eshelman School of Pharmacy and CRISPR Screening Facility collaborate on Malan Syndrome study.

    Health

    Smarter Organ Transplants

    The UNC Eshelman Institute for Innovation's Venture Studio invested in technology for smarter organ transplants.

    Shawn Hingtgen and Jillian Perry
    Research

    Treating the Untreatable

    New research funded by a NIH grant seeks to combat one of the most treatment-resistant cancers